In a retrospective analysis of the prognostic value of 50 immune checkpoints in BC, Fang and colleagues found that CTLA4 gene expression was upregulated in breast tumors compared to normal breast tissue, with the highest expression found in TNBC45. This evidence concerns the gene CTLA4 and breast cancer.